You pet can be an amazing companion on a trip, but it traveling can also cause undue stress. With a little preparation, both ...

Oct 8 (Reuters) - A U.S. judge has narrowed a consumer lawsuit accusing animal health giant Elanco (ELAN.N), opens new tab of monopolizing the market for some flea and tick treatments, causing dog and ...

Rated Red reviews today’s best flea and tick medicines in Pet 101. More Than 6K Arrested in FL Operation Could Trump Win Nobel Peace Prize 2026? What We Know Trump, Pulte Threats Fuel $19.5 Billion ...

It's the final hours of Prime Big Deal Days, and pet owners still have the chance to save big on must-have essentials. Shop major markdowns on dog leashes, flea and tick treatments, collars, cozy ...

BOCA RATON, Fla.--(BUSINESS WIRE)--During the ongoing government shutdown, ClinicalTrials.gov, the nation’s central registry for medical research and clinical studies, has gone offline, leaving ...

During the ongoing government shutdown, ClinicalTrials.gov, the nation’s central registry for medical research and clinical studies, has gone offline, leaving millions of patients with cancer and ...

NORTH CHICAGO - AbbVie (NYSE:ABBV), a $413 billion market cap biotechnology giant with over $58 billion in annual revenue, announced Monday that its Phase 2 trial evaluating onabotulinumtoxinA (BOTOX) ...

Artiva Biotherapeutics shares more than doubled after a trial for the company's rheumatoid arthritis treatment got fast-tracked. The stock rose more than twofold to $5.98 on Friday. The stock is still ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Bio-Gene Technology ...

Hypertension is a frequent chronic condition commonly affecting the elderly, but its incidence is increasing among younger individuals. The estimates predict that 1.28 billion individuals aged 30-79 ...

Results from safety analyses were generally consistent with the well-established safety profile of onabotulinumtoxinA. 1 NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today ...